In the global intention-to-treat population, Pola-R-CHP showed significant progression-free survival benefit over R-CHOP ...
Scientists have long suspected connections between heredity and disease, dating back to Hippocrates, who observed certain ...
Immusoft of CA, a clinical stage, engineered B cell company, today announced a historic achievement: the safe and well-tolerated re-dosing of a patient with a gene modified therapeutic product ...
The aim of immunotherapy strategies is to leverage cells in the patient's own immune system to destroy tumor cells. Using a ...
By examining genomic variation more closely, scientists can now identify new disease connections with greater speed and accuracy. For centuries, scientists have recognized that certain illnesses can ...
TipRanks on MSN
Regeneron’s Odronextamab Study Update: A Potential Game-Changer in B-Cell Malignancies
Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals recently updated its clinical ...
The Nobel Prize in Medicine was awarded on Monday to three scientists for discovering how a particular kind of cell can stop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback